Craft

Advanced
  • Home
  •  / Evecxia Therapeutics
Evecxia Therapeutics

Evecxia Therapeutics

Evecxia Therapeutics Summary

Company Summary

Overview
Evecxia Therapeutics is a clinical stage pharmaceutical company. It develops EVX-101, a 5-hydroxytryptophan (5-HTP) slow-release prescription drug for depression and other CNS disorders.
Type
Private
Status
Active
HQ
Durham, NC, US | view all locations
Website
https://evecxia.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • John Kaiser

    John Kaiser, Chief Executive Officer & Interim Chairman

    • Jacob Jacobsen

      Jacob Jacobsen, Chief Scientific Officer, Director

      • Marc Caron

        Marc Caron, Director

        LocationsView all

        1 location detected

        • Durham, NC HQ

          United States

          2 Davis Dr

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX